# Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK

> **NCT05973253** · PHASE2,PHASE3 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 74 (actual)

## Conditions studied

- Photorefractive Keratectomy

## Interventions

- **DRUG:** prepared drop of medroxy progestrone acetat 1%

## Key facts

- **NCT ID:** NCT05973253
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-21
- **Primary completion:** 2023-06-21
- **Final completion:** 2023-07-06
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2023-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05973253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05973253, "Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05973253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*